NCT06760234 2026-01-07
Multimodal Deep Learning Model Predicts Pancreatic Cancer Prognosis
Second Affiliated Hospital, School of Medicine, Zhejiang University
Completed
Clinical Trials
11 trialsNCT03404960 2025-10-10
Parpvax
University of Pennsylvania
Phase 1/2 Completed
NCT03307564 2024-04-25
Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT04119362 2024-03-07
PARAGON
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Completed
NCT04406571 2024-01-24
CAPANCOVID-19
CHU de Reims
Completed
NCT02427841 2023-09-06
Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
OHSU Knight Cancer Institute
Phase 2 Completed
NCT04289961 2023-08-30
PDAC Peripheral and Portal Vein Sampling
The Christie NHS Foundation Trust
Phase NA Completed
NCT02806687 2023-03-30
THERGAP-02
University Hospital, Toulouse
Phase 2 Completed
NCT02550327 2021-06-22
Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer
Baylor Research Institute
Phase EARLY_PHASE1 Completed
NCT02749136 2019-11-25
Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer
Asan Medical Center
Phase 2 Completed
NCT02680990 2018-02-28
REACT
Milton S. Hershey Medical Center
Phase NA Completed